SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, has appointed Sarah M. Romano as chief financial officer, effective Aug. 3, 2026. Based in the United States, Romano brings more than two decades of finance leadership experience in the medical technology and life sciences sectors and will help lead the company’s financial operations as it advances its global expansion strategy, including pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.
Most recently, Romano served as chief financial officer of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting and investor relations. Her experience in capital markets and corporate finance is expected to be instrumental as SS Innovations seeks to scale its operations and bring its cost-effective surgical robotic solutions to a broader market.
The appointment comes at a critical time for SS Innovations, which is focused on making robotic surgery affordable and accessible globally. The company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical robotic procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. The company’s strategy hinges on obtaining FDA clearance for the SSi Mantra, which would open the U.S. market—the largest for robotic surgery—and significantly boost revenue potential.
Romano’s track record in raising capital through public and private financings will be critical as SS Innovations funds its regulatory pathway and commercial expansion. The company’s financial leadership is expected to navigate the complexities of SEC reporting and investor relations, ensuring transparency and confidence among stakeholders. Her experience at Vicarious Surgical, where she focused on reducing cash burn and strengthening the balance sheet, aligns with SS Innovations’ goal of sustainable growth.
The press release announcing the appointment is available at https://ibn.fm/pAqlP. For more information about SS Innovations, visit their newsroom at https://ibn.fm/SSII.
